INDIANAPOLIS, July 23, 2015 /PRNewswire/ -- Eli Lilly and
Company (NYSE: LLY) today revealed plans to expand the Lilly
Biotechnology Center located in San
Diego, Calif. The expansion will effectively double Lilly's
research presence in San Diego as
the company seeks to develop new collaborations in one of the
world's leading regions for drug research and
development.
Set to be completed in 2016, the expansion will feature an
additional 175,000 square feet of working space and is expected to
generate up to 130 potential new job openings, yielding a 140
percent increase in the center's space and 70 percent increase in
its staff.
"San Diego has been an
important location for Lilly laboratories for more than a decade.
The city is a global hub for biomedical research and talent, where
collaboration between academic institutions and biotechnology
thrives," said Thomas F. Bumol,
Ph.D., senior vice president, biotechnology and immunology research
at Lilly. "We want to build on our success in San Diego through expanded collaborations that
ultimately allow us to bring better medicines to people faster than
ever before."
Importantly, the space will allow for closer collaboration among
Lilly experts in discovery chemistry and research technologies and
biotechnology, which will help accelerate the discovery of new
medicines within the company's core therapeutic areas, including
immunology.
The expansion also signifies Lilly's investment in obtaining
additional top scientific talent. Specifically, Lilly will be
recruiting experts in drug discovery in the disciplines of
biotechnology, chemistry and immunology and in immunological
clinical development.
"The molecular discovery capabilities at the Lilly Biotechnology
Center represent state of the art platforms to enable
pharmaceutical innovation across the continuum of small and large
molecules," said Alan D. Palkowitz,
Ph.D., vice president, discovery chemistry research &
technologies at Lilly. "The expanded investment will further
Lilly's leadership in these core areas and catalyze future
discoveries."
Lilly initially entered the San
Diego area in 2004 by acquiring Applied Molecular Evolution,
Inc., which now operates as a subsidiary of the company. The Lilly
Biotechnology Center was officially established in 2009 and is
located near the University of California, San
Diego, among other prominent biomedical research
institutions.
About Eli Lilly and Company
Lilly is a global
healthcare leader that unites caring with discovery to make life
better for people around the world. We were founded more than a
century ago by a man committed to creating high-quality medicines
that meet real needs, and today we remain true to that mission in
all our work. Across the globe, Lilly employees work to discover
and bring life-changing medicines to those who need them, improve
the understanding and management of disease, and give back to
communities through philanthropy and volunteerism. To learn more
about Lilly, please visit us at www.lilly.com and
newsroom.lilly.com/social-channels. C-LLY
Refer to: 317.997.1481; amy.sousa@lilly.com;
Amy Sousa; Eli Lilly and Company
Logo- http://photos.prnewswire.com/prnh/20031219/LLYLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/eli-lilly-and-company-announces-expansion-of-san-diego-biotechnology-center-300117264.html
SOURCE Eli Lilly and Company